ReviewDiabetologia2018
Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits.
Beatrice C Lupsa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
87 papers cite itlatest 60 shown
this paperpooled ittrialcites it
ReviewDiabetologia2018
Beatrice C Lupsa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.